期刊文献+

慢性缺血性心脏病患者接受冠状动脉内高剂量CD34^+干细胞移植:12个月的随访结果 被引量:1

Intra-coronary high-dose CD34^+stem cells in patients with chronic ischemic heart disease:A 12-month follow-up
下载PDF
导出
摘要 Current stem cell protocols for ischemic heart disease are limited by the smal l numbers of cells that can be obtained by bone marrow aspirate. To increase myo cardial delivery of bone marrow stem cells in patients with chronic ischemic hea rt disease(CIHD), we used granulocyte colony stimulating factor(G-CSF) for bone marrow mobilization of CD34+cells, enabling intracoronary infusion of large nu mbers of CD34+stem cells. Patients with CIHD(n=5) demonstrated significantly re duced numbers of CD34+cells mobilized by G-CSF in comparison to age-matched c ontrols. Sustained reduction in anginal symptoms and improvement in quality of l ife scores was seen in all patients following infusion of cells. Moreover, mean collateral flow grade at 12-month follow-up angiography significantly improved , indicating sustained myocardial neovascularization. No proliferative retinopat hy was induced and no in-stent restenosis seen. However, in two patients with d ocumented increase in collateral flow, complications arose, one developing an ac ute coronary syndrome and the other a lentigo maligna. These results demonstrate the feasibility of G-CSF mobilization, leukapheresis and intracoronary transfe r of CD34+stem cells in patients with CIHD, but longer-term studies are requir ed to ensure that this protocol is safe and effective. Current stem cell protocols for ischemic heart disease are limited by the small numbers of cells that can be obtained by bone marrow aspirate. To increase myocardial delivery of bone marrow stem cells in patients with chronic ischemic heart disease(CIHD), we used granulocyte colony stimulating factor(G-CSF) for bone marrow mobilization of CD34 + cells, enabling intracoronary infusion of large numbers of CD34 + stem cells. Patients with CIHD(n = 5) demonstrated significantly reduced numbers of CD34 + cells mobilized by G-CSF in comparison to age-matched controls. Sustained reduction in anginal symptoms and improvement in quality of life scores was seen in all patients following infusion of cells. Moreover, mean collateral flow grade at 12-month follow-up angiography significantly improved, indicating sustained myocardial neovasculafization. No proliferative retinopathy was induced and no in-stent restenosis seen.
  • 引文网络
  • 相关文献

同被引文献4

引证文献1

二级引证文献2

;
使用帮助 返回顶部